- Home
- HBAN vs TEVA Comparison
HBAN vs TEVA Comparison
Compare HBAN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBAN
- TEVA
- Stock Information
- Founded
- HBAN 1866
- TEVA 1901
- Country
- HBAN United States
- TEVA Israel
- Employees
- HBAN N/A
- TEVA N/A
- Industry
- HBAN Major Banks
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- HBAN Finance
- TEVA Health Care
- Exchange
- HBAN Nasdaq
- TEVA Nasdaq
- Market Cap
- HBAN 21.9B
- TEVA 18.4B
- IPO Year
- HBAN N/A
- TEVA N/A
- Fundamental
- Price
- HBAN $13.67
- TEVA $13.65
- Analyst Decision
- HBAN Buy
- TEVA Strong Buy
- Analyst Count
- HBAN 20
- TEVA 6
- Target Price
- HBAN $17.98
- TEVA $24.00
- AVG Volume (30 Days)
- HBAN 26.3M
- TEVA 12.0M
- Earning Date
- HBAN 04-17-2025
- TEVA 05-07-2025
- Dividend Yield
- HBAN 4.67%
- TEVA N/A
- EPS Growth
- HBAN 17.13
- TEVA N/A
- EPS
- HBAN 1.30
- TEVA N/A
- Revenue
- HBAN $7,105,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- HBAN $15.32
- TEVA $5.31
- Revenue Next Year
- HBAN $5.83
- TEVA $1.18
- P/E Ratio
- HBAN $10.52
- TEVA N/A
- Revenue Growth
- HBAN 5.18
- TEVA 4.41
- 52 Week Low
- HBAN $11.92
- TEVA $12.47
- 52 Week High
- HBAN $18.45
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- HBAN 45.26
- TEVA 37.96
- Support Level
- HBAN $13.10
- TEVA $13.24
- Resistance Level
- HBAN $13.63
- TEVA $13.83
- Average True Range (ATR)
- HBAN 0.76
- TEVA 0.80
- MACD
- HBAN 0.03
- TEVA -0.03
- Stochastic Oscillator
- HBAN 52.87
- TEVA 38.44
About HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.